IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to evaluate and compare the effect of iron isomaltoside 1000 to
iron sucrose in its ability to increase haemoglobin (Hb) in subjects with IDA when oral iron
preparations are ineffective or cannot be used or where there is a clinical need to deliver
iron rapidly.
Phase:
Phase 3
Details
Lead Sponsor:
Pharmacosmos A/S
Collaborators:
BioStata ClinStar, LLC LabCorp
Treatments:
Ferric Compounds Ferric Oxide, Saccharated Iron Iron isomaltoside 1000